← Leaderboards
Mark A Jutila
Montana State University (Bozeman)
$13,420,411
Attributed
$13,849,189
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$13,849,189 · 18
By mechanism
P01$5,916,715 · 1
P30$1,638,820 · 1
R21$1,537,200 · 4
P20$1,479,349 · 7
U54$1,419,780 · 2
N01$1,016,430 · 1
Top collaborators
- Agnieszka Rynda-Apple2 shared
- Trevor Douglas1 shared
Most similar at Montana State University (Bozeman)
Same institution · by research overlap
- David W Pascual$22,231,160
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionCellsImmune ResponseCenters Of Research ExcellenceBiologicalLungBaseIn VivoAgonistResourcesProgramsGrantFundingFutureFlow CytometryResearch PersonnelPathogenMacrophagePathogenesisServicesResearch Project GrantsInflammationVaccinesCoxiella Burnetii
Grant awards (35)
Optimized phage therapy for Brucella infection$180,000
R21 · FY2020 · AI · contact PI
Optimized phage therapy for Brucella infection$180,000
R21 · FY2019 · AI · contact PI
Cellular Analysis Core$327,764
P30 · FY2018 · GM · contact PI
Engineered virus-like nanoparticles targeting immunity needed for pan flu vaccine$461,556
R01 · FY2017 · AI
Cellular Analysis Core$327,764
P30 · FY2017 · GM · contact PI
Role of type I IFN and human TLR4 in Coxiella burnetii pathogenesis$180,000
R21 · FY2017 · AI · contact PI
Cellular Analysis Core$327,764
P30 · FY2016 · GM · contact PI
Role of type I IFN and human TLR4 in Coxiella burnetii pathogenesis$216,000
R21 · FY2016 · AI · contact PI
Development of novel, safe and efficacious Coxiella burnetii vaccine$180,000
R21 · FY2016 · AI
Cellular Analysis Core$327,764
P30 · FY2015 · GM · contact PI
Development of novel, safe and efficacious Coxiella burnetii vaccine$216,000
R21 · FY2015 · AI
Cellular Analysis Core$327,764
P30 · FY2014 · GM · contact PI
Role of Toll-like receptors in Coxiella burnetii infection$169,200
R21 · FY2013 · AI · contact PI
CAMs as counter measures against infectious and inflammatory disease$1,152,596
P01 · FY2012 · AT · contact PI
Role of Toll-like receptors in Coxiella burnetii infection$216,000
R21 · FY2012 · AI · contact PI
CAMs as counter measures against infectious and inflammatory disease$1,176,119
P01 · FY2011 · AT · contact PI
MT VET COBRE II CORE B: CELLULAR ANALYSIS CORE$287,616
P20 · FY2011 · RR · contact PI
CAMs as counter measures against infectious and inflammatory disease$1,188,000
P01 · FY2010 · AT · contact PI
MT VET COBRE II CORE B: CELLULAR ANALYSIS CORE$442,140
P20 · FY2010 · RR · contact PI
CAMs as counter measures against infectious and inflammatory disease$1,200,000
P01 · FY2009 · AT · contact PI
Enhancement of Innate Immunity Against Coxiella Pneumonia$188,138
U54 · FY2009 · AI · contact PI
MT VET COBRE CORE C: CELL ANALYSIS CORE$112,859
P20 · FY2009 · RR · contact PI
CAMs as counter measures against infectious and inflammatory disease$1,200,000
P01 · FY2008 · AT · contact PI
Enhancement of Innate Immunity Against Coxiella Pheumonia$378,880
U54 · FY2008 · AI · contact PI
MT VET COBRE CORE C: CELL ANALYSIS CORE$120,392
P20 · FY2008 · RR · contact PI
INNATE IMMUNE RECEPTORS AND ADJVANT DISCOVERY$1,016,430
N01 · FY2007 · AI · contact PI
Enhancement of Innate Immunity Against Coxiella Pheumonia$344,151
U54 · FY2007 · AI · contact PI
MT VET COBRE CORE C: CELL ANALYSIS CORE$128,657
P20 · FY2007 · RR · contact PI
Enhancement of Innate Immunity Against Coxiella Pheumonia$255,543
U54 · FY2006 · AI · contact PI
MT VET COBRE CORE C: CELL ANALYSIS CORE$159,471
P20 · FY2006 · RR · contact PI
Enhancement of Innate Immunity Against Coxiella Pheumonia$253,068
U54 · FY2005 · AI
MT VET COBRE: CELL ANALYSIS CORE$124,139
P20 · FY2005 · RR
MT VET COBRE: CELL ANALYSIS CORE$104,075
P20 · FY2004 · RR
E-SELECTIN LIGANDS ON LYMPHOCYTES$192,473
R01 · FY2001 · AI
E-SELECTIN LIGANDS ON LYMPHOCYTES$186,866
R01 · FY2000 · AI